Zang DY - Search Results

1

Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer.

Shin SJ, Jeong JH, Park YS, Lee KH, Shim BY, Kim TW, Oh DY, Lee MA, Kim YT, Kim YH, Zang DY, Roh JK, Ahn JB. Shin SJ, et al. Among authors: zang dy. Invest New Drugs. 2011 Oct;29(5):1073-80. doi: 10.1007/s10637-010-9418-2. Epub 2010 Mar 21. Invest New Drugs. 2011. PMID: 20306116

2

A randomized trial comparing cisplatin plus 5-fluorouracil with or without levamisole in operable gastric cancer.

Choi JS, Lee KH, Ahn MJ, Lee JS, Lee JH, Zang DY, Suh CW, Kim SW, Kim WG, Kim JC, Kim SK, Park KC, Lee MS, Kim SH. Choi JS, et al. Among authors: zang dy. Korean J Intern Med. 1997 Jun;12(2):155-62. doi: 10.3904/kjim.1997.12.2.155. Korean J Intern Med. 1997. PMID: 9439150 Free PMC article. Clinical Trial.

3

Phase II trial of a novel platinum analog, SKI 2053R, in patients with previously untreated extensive-stage small-cell lung cancer.

Zang DY, Lee KH, Lee JS, Lee JH, Kim WK, Kim SH, Kim WD, Kim DS, Kim JH, Kim BS, Cho YB, Kim DK, Kim KH. Zang DY, et al. Am J Clin Oncol. 1999 Oct;22(5):495-8. doi: 10.1097/00000421-199910000-00015. Am J Clin Oncol. 1999. PMID: 10521066 Clinical Trial.

4

Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: a Korean Cancer Study Group trial.

Kim TW, Kang WK, Chang HM, Park JO, Ryoo BY, Ahn JS, Zang DY, Lee KH, Kang YK, Kim SR, Kim HK; Korean Cancer Study Group. Kim TW, et al. Among authors: zang dy. Acta Oncol. 2005;44(3):230-5. doi: 10.1080/02841860510029590. Acta Oncol. 2005. PMID: 16076694 Clinical Trial.

5

Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age.

Zang DY, Yang DH, Lee HW, Hwang SW, Song HH, Jung JY, Kwon JH, Kim HJ, Kim JH, Park SR, Kim MJ, Jang KM, Park CK, Kim JH, Lee BH. Zang DY, et al. Cancer Chemother Pharmacol. 2009 Feb;63(3):509-16. doi: 10.1007/s00280-008-0768-9. Epub 2008 May 15. Cancer Chemother Pharmacol. 2009. PMID: 18481067 Clinical Trial.

6

A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.

Lee JL, Kang YK, Kang HJ, Lee KH, Zang DY, Ryoo BY, Kim JG, Park SR, Kang WK, Shin DB, Ryu MH, Chang HM, Kim TW, Baek JH, Min YJ. Lee JL, et al. Among authors: zang dy. Br J Cancer. 2008 Aug 19;99(4):584-90. doi: 10.1038/sj.bjc.6604536. Epub 2008 Jul 29. Br J Cancer. 2008. PMID: 18665164 Free PMC article. Clinical Trial.

7

Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study.

Lee KH, Kim MK, Kim YH, Ryoo BY, Lim HY, Song HS, Kim HK, Lee MA, Im SA, Chang HM, Cho JY, Zang DY, Kim BS, Kim JS. Lee KH, et al. Among authors: zang dy. Cancer Chemother Pharmacol. 2009 Jul;64(2):317-25. doi: 10.1007/s00280-008-0873-9. Epub 2008 Nov 26. Cancer Chemother Pharmacol. 2009. PMID: 19034448 Clinical Trial.

8

Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancer.

Zang DY, Lee BH, Park HC, Song HH, Kim HJ, Jung JY, Kim JH, Kim HY, Kwon JH, Hwang SW, Park SR, Park CH, Kim KO, Kim MJ, Jang KM. Zang DY, et al. Ann Oncol. 2009 May;20(5):892-6. doi: 10.1093/annonc/mdn721. Epub 2009 Jan 19. Ann Oncol. 2009. PMID: 19153122 Free article. Clinical Trial.

9

Randomized, multicenter, phase III trial of heptaplatin 1-hour infusion and 5-fluorouracil combination chemotherapy comparing with cisplatin and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer.

Lee KH, Hyun MS, Kim HK, Jin HM, Yang J, Song HS, Do YR, Ryoo HM, Chung JS, Zang DY, Lim HY, Jin JY, Yim CY, Park HS, Kim JS, Sohn CH, Lee SN. Lee KH, et al. Among authors: zang dy. Cancer Res Treat. 2009 Mar;41(1):12-8. doi: 10.4143/crt.2009.41.1.12. Epub 2009 Mar 31. Cancer Res Treat. 2009. PMID: 19688066 Free PMC article.

10

Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer.

Kwon JH, Kim JH, Lee JA, Shin HC, Kim HJ, Song HH, Jung JY, Kim HY, Choi DR, Kim HS, Park YI, Zang DY. Kwon JH, et al. Among authors: zang dy. Cancer Chemother Pharmacol. 2010 Oct;66(5):889-97. doi: 10.1007/s00280-009-1235-y. Epub 2010 Jan 21. Cancer Chemother Pharmacol. 2010. PMID: 20091311 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters